Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Rang în acțiuni #492
Operating globally, Becton, Dickinson and Company (BD) is a prominent... Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
Preț acțiune
$183.43
Capitalizare de piață
$50.54B
Schimbare (1 zi)
2.13%
Schimbare (1 an)
29.20%
Țară
US
Tranzacționează Becton, Dickinson and Company (BDX)

Categorie

Raport P/E pentru Becton, Dickinson and Company (BDX)
Raport P/E la data de September 2026 TTM: 55.09
Conform celor mai recente rapoarte financiare și prețului acțiunilor Becton, Dickinson and Company, raportul P/E actual (TTM) este 55.09. La sfârșitul anului 2024, compania avea un P/E de 40.97.
Istoricul raportului P/E pentru Becton, Dickinson and Company din 2000 până în 2026
Raportul P/E la sfârșitul fiecărui an
An Raport P/E Schimbă
2026 (TTM) 55.09 72.33%
2025 31.97 -21.98%
2024 40.97 -17.84%
2023 49.87 39.71%
2022 35.70 7.72%
2021 33.14 -54.23%
2020 72.41 34.11%
2019 53.99 -74.78%
2018 214.12 463.11%
2017 38.02 -0.43%
2016 38.19 1.32%
2015 37.69 108.24%
2014 18.10 22.98%
2013 14.72 8.89%
2012 13.52 8.66%
2011 12.44 -3.18%
2010 12.85 -3.24%
2009 13.28 -21.73%
2008 16.96 -23.68%
2007 22.23 -1.92%
2006 22.66 27.31%
2005 17.80 -34.36%
2004 27.12 65.54%
2003 16.38 10.04%
2002 14.89 -35.06%
2001 22.93 38.04%
2000 16.61 0.00%
Raportul P/E pentru companii similare sau concurenți
Companie P/E Ratio Diferență P/E Ratio Țara
42.71 -22.49%
US
27.35 -50.35%
FR
- -
JP
- -
CH
- -
US
Cum interpretezi un P/E ratio?

Raportul Preț/Câștig (P/E Ratio) măsoară relația dintre prețul acțiunii unei companii și câștigul pe acțiune.
Un P/E scăzut dar pozitiv indică o companie cu profituri mari în raport cu evaluarea actuală și ar putea fi subevaluată. Un P/E negativ mare (aproape de 0) indică pierderi majore.

Companiile cu un P/E peste 30 sau negativ sunt considerate în general „acțiuni de creștere”, adică investitorii se așteaptă la creștere sau profitabilitate viitoare.

Companiile cu un P/E pozitiv sub 10 sunt considerate „acțiuni de valoare”, adică sunt deja profitabile, dar cu șanse mici de creștere suplimentară.